CHRISTY BABIS: Open Payments
NPI 1821775677 · AUSTIN, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,879 in 87 payments from 15 companies in 2025. Trend: 2023 $492 · 2024 $1,782 · 2025 $1,879
Food & beverage: $1,879
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 17 | $531 |
| Novartis Pharmaceuticals Corporation | 18 | $384 |
| Amgen Inc. | 24 | $364 |
| Esperion Therapeutics, Inc. | 13 | $156 |
| Medtronic, Inc. | 1 | $109 |
| Lilly USA, LLC | 4 | $84 |
| PFIZER INC. | 2 | $46 |
| Inspire Medical Systems, Inc. | 1 | $35 |
| GlaxoSmithKline, LLC. | 1 | $30 |
| E.R. Squibb & Sons, L.L.C. | 1 | $27 |
Products named: Ozempic, LEQVIO, REPATHA, NEXLETOL, COREVALVE EVOLUT R, ZEPBOUND, ELIQUIS, INSPIRE.
Industry payments across TX — which companies pay providers there.
